These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22999641)

  • 1. Laboratory exposures to brucella in the UK and Ireland.
    Cooke RP; Chisnall C
    J Hosp Infect; 2012 Nov; 82(3):218. PubMed ID: 22999641
    [No Abstract]   [Full Text] [Related]  

  • 2. Anatomy of an exposure: a hospital lab's recovery of Brucella melitensis.
    Gannon CK
    MLO Med Lab Obs; 2003 Sep; 35(9):22-5. PubMed ID: 14524145
    [No Abstract]   [Full Text] [Related]  

  • 3. A large exposure to Brucella melitensis in a diagnostic laboratory.
    Sam IC; Karunakaran R; Kamarulzaman A; Ponnampalavanar S; Syed Omar SF; Ng KP; Mohd Yusof MY; Hooi PS; Jafar FL; Abubakar S
    J Hosp Infect; 2012 Apr; 80(4):321-5. PubMed ID: 22237130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory exposure to Brucella melitensis in Denmark: a prospective study.
    Knudsen A; Kronborg G; Dahl Knudsen J; Lebech AM
    J Hosp Infect; 2013 Nov; 85(3):237-9. PubMed ID: 24070633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of laboratory-acquired brucellosis.
    Robichaud S; Libman M; Behr M; Rubin E
    Clin Infect Dis; 2004 Jun; 38(12):e119-22. PubMed ID: 15227634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure of hospital personnel to Brucella melitensis and occurrence of laboratory-acquired disease in an endemic area.
    Yagupsky P; Peled N; Riesenberg K; Banai M
    Scand J Infect Dis; 2000; 32(1):31-5. PubMed ID: 10716074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of laboratory-acquired brucellosis: significant side effects of prophylaxis.
    Maley MW; Kociuba K; Chan RC
    Clin Infect Dis; 2006 Feb; 42(3):433-4. PubMed ID: 16392095
    [No Abstract]   [Full Text] [Related]  

  • 8. An accidental laboratory exposure to
    Wong C; Ng SY; Tan SH
    J Med Microbiol; 2018 Jul; 67(7):1012-1016. PubMed ID: 29846154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak of Brucella melitensis among microbiology laboratory workers.
    Martin-Mazuelos E; Nogales MC; Florez C; Gómez-Mateos JM; Lozano F; Sanchez A
    J Clin Microbiol; 1994 Aug; 32(8):2035-6. PubMed ID: 7989566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid MALDI-TOF-based identification of Brucella melitensis from positive blood culture vials may prevent laboratory-acquired infections.
    Becker SL; Zange S; Brockmeyer M; Grün U; Halfmann A
    J Hosp Infect; 2018 Sep; 100(1):117-119. PubMed ID: 29653133
    [No Abstract]   [Full Text] [Related]  

  • 11. Brucellosis: a re-emerging zoonosis.
    Seleem MN; Boyle SM; Sriranganathan N
    Vet Microbiol; 2010 Jan; 140(3-4):392-8. PubMed ID: 19604656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital-associated transmission of Brucella melitensis outside the laboratory.
    Lowe CF; Showler AJ; Perera S; McIntyre S; Qureshi R; Patel SN; Allen V; Devlin HR; Muller MP
    Emerg Infect Dis; 2015 Jan; 21(1):150-2. PubMed ID: 25531198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human brucellosis in South Africa: Public health and diagnostic pitfalls.
    Wojno JM; Moodley C; Pienaar J; Beylis N; Jacobsz L; Nicol MP; Rossouw J; Bamford C
    S Afr Med J; 2016 Aug; 106(9):883-5. PubMed ID: 27601111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brucellae growing on Thayer-Martin medium: a source of inadvertent exposure for laboratory personnel in endemic areas.
    Yagupsky P
    J Med Microbiol; 2014 Jan; 63(Pt 1):148-149. PubMed ID: 24072760
    [No Abstract]   [Full Text] [Related]  

  • 15. Case records of the Massachusetts General Hospital. Case 34-2008. A 58-year-old woman with neck pain and fever.
    Gerberding JL; Romero JM; Ferraro MJ
    N Engl J Med; 2008 Oct; 359(18):1942-9. PubMed ID: 18971496
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infection.
    Atkins HS; Spencer S; Brew SD; Jenner DC; Sefton AM; MacMillan AP; Brooks TJ; Simpson AJ
    Int J Antimicrob Agents; 2010 Jul; 36(1):66-8. PubMed ID: 20022474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MLVA as an Epidemiological Tool To Trace Back Brucella melitensis Biovar 1 Re-Emergence in Italy.
    De Massis F; Ancora M; Atzeni M; Rolesu S; Bandino E; Danzetta ML; Zilli K; Di Giannatale E; Scacchia M
    Transbound Emerg Dis; 2015 Oct; 62(5):463-9. PubMed ID: 26194658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case report of spontaneous abortion caused by Brucella melitensis biovar 3.
    Yang HX; Feng JJ; Zhang QX; Hao RE; Yao SX; Zhao R; Piao DR; Cui BY; Jiang H
    Infect Dis Poverty; 2018 May; 7(1):31. PubMed ID: 29716658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of vaccines in brucellosis control and eradication programs for livestock.
    Olsen SC; Stoffregen WS
    Expert Rev Vaccines; 2005 Dec; 4(6):915-28. PubMed ID: 16372886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory-acquired brucellosis.
    Noviello S; Gallo R; Kelly M; Limberger RJ; DeAngelis K; Cain L; Wallace B; Dumas N
    Emerg Infect Dis; 2004 Oct; 10(10):1848-50. PubMed ID: 15504276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.